Food News and Research

RSS

UF Health researcher finds simple way to treat immune-related disorder in mice

A University of Florida Health researcher has found a simple, rapid way to treat an immune-related disorder in mice, an approach that could eventually help multiple sclerosis patients after further research.

25 Nov 2015

Takeda receives FDA approval for NINLARO (ixazomib) capsules to treat patients with multiple myeloma

Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration has approved NINLARO (ixazomib) capsules, the first and only oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a once-weekly pill.

25 Nov 2015

First seasonal influenza vaccine containing adjuvant now approved by FDA

The U.S. Food and Drug Administration today approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza virus strains (two subtype A and one type B), is approved for the prevention of seasonal influenza in people 65 years of age and older.

25 Nov 2015

Portrazza approved to treat patients with advanced squamous non-small cell lung cancer

The U.S. Food and Drug Administration today approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer.

24 Nov 2015

New collaboration aims to develop novel generation artificial pancreas

Debiotech SA, the ARTORG Center for Biomedical Engineering Research of the University of Bern - and the Division of Endocrinology, Diabetes and Clinical Nutrition of the Bern University Hospital "Inselspital" are proud to announce the start of an exclusive collaboration to develop a novel generation artificial pancreas.

24 Nov 2015

Impax releases generic version of dutasteride capsules, 0.5 mg

Impax Laboratories, Inc. today announced that on November 20, the Company's development and manufacturing partner received final approval by the U.S. Food and Drug Administration for a generic version of dutasteride capsules, 0.5 mg.

24 Nov 2015

Mylan releases Clozapine Orally Disintegrating Tablets in U.S.

Mylan N.V. today announced the U.S. launch of Clozapine Orally Disintegrating Tablets, 25 mg and 100 mg, the generic version of Jazz Pharmaceutical's FazaClo.

24 Nov 2015

Food smells activate impulse areas of the brain linked with obsessive-compulsive disorder in obese children

The area of the brain associated with impulsivity and the development of obsessive-compulsive disorder is activated in obese children when introduced to food smells, according to a study being presented next week at the annual meeting of the Radiological Society of North America.

24 Nov 2015

Green Cross' Biologics License Application for IVIG-SN submitted to FDA

Green Cross Corporation, a South Korean biopharmaceutical company, today announced that it has submitted its Biologics License Application for IVIG-SN (human normal immunoglobulin G for intravenous administration) to the United States Food and Drug Administration.

24 Nov 2015

Adding seaweed to processed foods reduces cardiovascular diseases

Adding seaweed to processed foods such as frozen pizzas, hot dogs and dried pasta will reduce cardiovascular diseases, concludes a new scientific article. One suggestion is to replace 5% of the flour in pizza dough with dried and granulated seaweed.

24 Nov 2015

High-fat diet appears to prompt immune cells to start consuming connections between neurons

When a high-fat diet causes us to become obese, it also appears to prompt normally bustling immune cells in our brain to become sedentary and start consuming the connections between our neurons, scientists say.

24 Nov 2015

BioThrax approved to prevent disease after exposure to anthrax spores

The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.

24 Nov 2015

Opdivo (nivolumab) approved to treat patients with advanced renal cell carcinoma

The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.

23 Nov 2015

Stony Brook Medicine expert shares tips to minimize heartburn during holiday season

The holiday season is upon us and most days and nights will be filled with delicious festivities! However, with millions of Americans suffering from heartburn, fear may set in when anticipating these celebrations.

23 Nov 2015

Hiding cigarettes at convenience stores significantly reduces teenagers' smoking risk

Keeping tobacco products out of view in convenience stores significantly reduces teenagers' susceptibility to future cigarette use compared to when tobacco advertising and products are visible, according to a new RAND Corporation study.

23 Nov 2015

New report reviews current WIC food packages

Women and children who participate in the WIC program have low or inadequate intakes of several key nutrients that could be addressed with changes to the program's food packages, says a new report from the National Academies of Sciences, Engineering, and Medicine.

23 Nov 2015

ADMT withdraws Premarket Notification 510(k) application for Angiodroid Injector

ADM Tronics Unlimited, Inc. has announced that Angiodroid America, Inc. has withdrawn its Premarket Notification 510(k) application filed with the US Food and Drug Administration for Angiodroid The CO2 Injector for Angiography (the "Angiodroid Injector").

22 Nov 2015

Brain imaging reveals distinctive aspects of high-inflammation depression

About one third of people with depression have high levels of inflammation markers in their blood. New research indicates that persistent inflammation affects the brain in ways that are connected with stubborn symptoms of depression, such as anhedonia, the inability to experience pleasure.

21 Nov 2015

Mason researchers patent new breast cancer treatment

George Mason University researchers have patented a new breast cancer treatment that uses a common malaria drug to stop cancer in its beginning stages.

21 Nov 2015

TVA Medical announces results from multicenter clinical study of everlinQ endoAVF System

TVA Medical, Inc., announced clinical trial results from a prospective, multicenter clinical study evaluating the everlinQ endoAVF System. This innovative medical technology creates hemodialysis access using vascular sites not traditionally used by surgeons for people with end-stage kidney disease (ESKD).

21 Nov 2015

Food News and Research

UF Health researcher finds simple way to treat immune-related disorder in mice

Takeda receives FDA approval for NINLARO (ixazomib) capsules to treat patients with multiple myeloma

First seasonal influenza vaccine containing adjuvant now approved by FDA

Portrazza approved to treat patients with advanced squamous non-small cell lung cancer

New collaboration aims to develop novel generation artificial pancreas

Impax releases generic version of dutasteride capsules, 0.5 mg

Mylan releases Clozapine Orally Disintegrating Tablets in U.S.

Food smells activate impulse areas of the brain linked with obsessive-compulsive disorder in obese children

Green Cross' Biologics License Application for IVIG-SN submitted to FDA

Adding seaweed to processed foods reduces cardiovascular diseases

High-fat diet appears to prompt immune cells to start consuming connections between neurons

BioThrax approved to prevent disease after exposure to anthrax spores

Opdivo (nivolumab) approved to treat patients with advanced renal cell carcinoma

Stony Brook Medicine expert shares tips to minimize heartburn during holiday season

Hiding cigarettes at convenience stores significantly reduces teenagers' smoking risk

New report reviews current WIC food packages

ADMT withdraws Premarket Notification 510(k) application for Angiodroid Injector

Brain imaging reveals distinctive aspects of high-inflammation depression

Mason researchers patent new breast cancer treatment

TVA Medical announces results from multicenter clinical study of everlinQ endoAVF System

Enhancing confidence in chemical ionization spectrometry data eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News